
Champions Oncology, Inc.
CSBRNasdaqCIK 771856HealthcareFiscal year ends Apr 30
Reports and events: 248 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-08-2915:18 ET | DEF 14A | Proxy statementPeriod 2022-08-29 | 0001628280-22-023824 |
| 2022-07-2216:28 ET | 10-K | Annual reportPeriod 2022-04-30 | 0001628280-22-019309 |
| 2022-07-2115:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-019249 |
| 2022-03-1517:18 ET | 10-Q | Quarterly reportPeriod 2022-01-31 | 0001628280-22-006298 |
| 2022-03-1516:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-006255 |
| 2021-12-1317:00 ET | 10-Q | Quarterly reportPeriod 2021-10-31 | 0001628280-21-024951 |
| 2021-12-1315:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-21-024928 |
| 2021-10-2112:51 ET | 8-K | 5.07 Shareholder vote results | 0001628280-21-020321 |
| 2021-09-1317:00 ET | 10-Q | Quarterly reportPeriod 2021-07-31 | 0001628280-21-018495 |
| 2021-09-1316:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-21-018477 |
| 2021-08-3017:07 ET | DEF 14A | Proxy statementPeriod 2021-08-30 | 0001628280-21-017794 |
| 2021-07-2617:23 ET | 10-K | Annual reportPeriod 2021-04-30 | 0001628280-21-014464 |
| 2021-07-2208:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-21-014235 |
| 2021-03-1515:11 ET | 10-Q | Quarterly reportPeriod 2021-01-31 | 0001628280-21-004710 |
| 2021-03-1116:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-21-004535 |
| 2021-02-1210:57 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-21-002048 |
| 2020-12-1417:19 ET | 10-Q | Quarterly reportPeriod 2020-10-31 | 0001628280-20-017479 |
| 2020-12-1416:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-20-017470 |
| 2020-10-2115:24 ET | 8-K | 5.07 Shareholder vote results | 0001628280-20-014644 |
| 2020-10-1517:09 ET | 8-K | 9.01 Financial statements and exhibits | 0001628280-20-014503 |
| 2020-09-1416:45 ET | 10-Q | Quarterly reportPeriod 2020-07-31 | 0001628280-20-013559 |
| 2020-09-1416:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-20-013549 |
| 2020-08-2816:17 ET | DEF 14A | Proxy statementPeriod 2020-04-30 | 0001628280-20-013113 |
| 2020-07-2817:29 ET | 10-K | Annual reportPeriod 2020-04-30 | 0001628280-20-010734 |
| 2020-07-2716:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-20-010661 |
| 2020-03-3017:22 ET | 8-K | 3.02 Unregistered sale of equity | 0001628280-20-004386 |
| 2020-03-1616:30 ET | 10-Q | Quarterly reportPeriod 2020-01-31 | 0001628280-20-003637 |
| 2020-03-1216:05 ET | 8-K | 2.02 Results of operations | 0001628280-20-003461 |
| 2020-01-0315:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-20-000084 |
| 2019-12-1616:33 ET | 10-Q | Quarterly reportPeriod 2019-10-31 | 0001628280-19-015106 |
| 2019-12-1616:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-19-015102 |
| 2019-10-1613:27 ET | 8-K | 5.07 Shareholder vote results | 0001628280-19-012310 |
| 2019-09-1616:59 ET | 10-Q | Quarterly reportPeriod 2019-07-31 | 0001628280-19-011753 |
| 2019-09-1616:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-19-011740 |
| 2019-09-0511:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-19-011423 |
| 2019-08-2816:39 ET | DEF 14A | Proxy statementPeriod 2019-04-30 | 0001628280-19-011252 |
| 2019-07-2916:25 ET | 10-K | Annual reportPeriod 2019-04-30 | 0001628280-19-009139 |
| 2019-07-1516:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-19-008752 |
| 2019-03-1817:01 ET | 10-Q | Quarterly reportPeriod 2019-01-31 | 0001628280-19-003086 |
| 2019-03-1816:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-19-003074 |
| 2019-01-0710:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-19-000136 |
| 2018-12-1716:58 ET | 10-Q | Quarterly reportPeriod 2018-10-31 | 0001628280-18-015187 |
| 2018-12-1716:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-18-015177 |
| 2018-10-1610:15 ET | 8-K | 5.07 Shareholder vote results | 0001628280-18-012569 |
| 2018-09-1416:12 ET | 10-Q | Quarterly reportPeriod 2018-07-31 | 0001628280-18-011874 |
| 2018-09-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-18-011830 |
| 2018-08-2816:09 ET | DEF 14A | Proxy statementPeriod 2018-04-30 | 0001628280-18-011478 |
| 2018-07-3017:14 ET | 10-K | Annual reportPeriod 2018-04-30 | 0001628280-18-009773 |
| 2018-07-2616:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-18-009635 |
| 2018-03-1916:30 ET | 10-Q | Quarterly reportPeriod 2018-01-31 | 0001628280-18-003346 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.